Phase 2 results (48 weeks): 1mg dose: 8.7% average weight loss 4mg dose: 17.1% average weight loss 8mg dose: 22.8% average weight loss 12mg dose: 24.2% average weight loss Placebo: 2.1% average weight loss These numbers came from a 48-week study period, six months shorter than the 72-week SURMOUNT trials
Furthermore, incretin-based therapies can also improve mitochondrial function and reduce apoptosis by increasing anti-apoptotic protein Bcl-2 expression and lowering pro-apoptotic BAX signaling, thereby promoting neuronal survival in dopaminergic cell lines (Hlscher, 2025)
Free radicals: properties, sources, targets, and their implication in various diseases
35 With the development of endoscopic technology, doctors can evaluate the condition of the patients colonic mucosa more clearly, which enables more accurate diagnosis and treatment of UC
We ensure that our L-theanine supplements are both safe and effective
Hospital protocols now include GLP-1 medication history when treating COVID-positive patients with abdominal pain